Fig. (7)
X-ray crystallographic complexes of
a
) JMJD2A with NOG,
b
) FBXL11 with 2-OG,
c
) PHF8 with NOG,
d-f
) JMJD2A with an oxalyltyrosine derivative, 2,4-PDCA and 5-carboxy-8-hydroxyquinoline respectively.